Sponsors

Patient group engagement before the protocol is locked

A case-study style guide to using patient group input before protocol, visit, and recruitment workflow decisions become difficult to change.

Patient group engagement is strongest before the protocol, visit schedule, outreach language, and follow-up workflow are fixed.

In this guide

Key points

  • Patient groups can help pressure-test visit burden, study language, referral paths, cost questions, and follow-up expectations before recruitment opens.
  • Late engagement can still improve materials, but earlier engagement can expose design and workflow barriers while changes are more practical.
  • TrialsNest can translate engagement findings into clearer public pages, prescreen expectations, coordinator scripts, and blocker reporting categories.

Engage before the important decisions are fixed

Patient engagement is weaker when it happens after all important decisions are already made. A patient group can comment on a flyer, but it can do more if engaged before the protocol, visit schedule, eligibility assumptions, and recruitment workflow are locked.

FDA patient-focused drug development guidance describes methodological approaches for collecting comprehensive and representative patient and caregiver input. CTTI patient group engagement recommendations also emphasize engagement across the clinical trial continuum.

Case-study scenario

A sponsor designs a study with frequent in-person visits, technical patient-facing copy, and narrow scheduling windows. A patient group review after launch identifies travel burden, unclear study language, and caregiver constraints. At that point, fixes are slower and more limited.

If engaged earlier, the same patient group could have helped pressure-test visit burden, language, referral pathways, reimbursement questions, and follow-up expectations before launch.

Questions to ask patient groups

Ask what parts of participation are hardest to understand, which visits create the most practical burden, what language sounds confusing or overstated, which outreach channels are trusted, and what patients should know before prescreening.

Also ask what would make coordinator follow-up feel clear and respectful, and which costs or logistics should be discussed earlier in the process.

Turn input into operating changes

TrialsNest can translate patient group input into operational content: clearer study pages, better prescreen expectations, coordinator follow-up prompts, and reporting categories that capture real patient barriers instead of vague recruitment slow notes.

The best engagement work produces decisions the team can act on: clearer language, better visit preparation, more realistic scheduling, improved source strategy, or earlier escalation of participant-burden issues.

Sources used for this case study

FDA patient-focused drug development guidance: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/patient-focused-drug-development-collecting-comprehensive-and-representative-input

CTTI patient engagement resources: https://ctti-clinicaltrials.org/patient-engagement/

CTTI patient group engagement recommendations: https://ctti-clinicaltrials.org/wp-content/uploads/2021/06/CTTI_Patient_Group_Engagement_Recs.pdf

Sources and editorial notes

Published .

This guide explains recruitment work and questions to discuss with your team.

This information is educational. Your study team makes medical, eligibility, and enrollment decisions.

See TrialsNest in action

Bring this workflow into one place.

Manage inquiries, follow-ups, records, and visits. Keep sponsors updated on progress.

Aggregate study reporting

Sponsor portfolio

6 active studies482 inquiries18 research sites
Study APhase IIb

39 / 50 enrolled78%

Study BPhase III

74 / 120 enrolled62%

Study CPhase I

9 / 10 enrolled90%

Keep reading